Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion type Assertion NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_head.
- NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_provenance.
- NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion evidence source_evidence_literature NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_provenance.
- NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion SIO_000772 15788669 NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_provenance.
- NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion wasDerivedFrom befree-2016 NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_provenance.
- NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion wasGeneratedBy ECO_0000203 NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_provenance.